Status:
UNKNOWN
Acute Respiratory Failure and COVID-19 in Real Life
Lead Sponsor:
University of Milan
Conditions:
Coronavirus Infections
Respiratory Failure
Eligibility:
All Genders
18+ years
Brief Summary
In December 2019 a new kind of virus was identified in China as the responsible of severe acute respiratory syndrome (SARS) and interstitial pneumonia. Severe acute respiratory syndrome coronavirus 2 ...
Detailed Description
All consecutive adult COVID-19 patients admitted to our Respiratory Unit will be enrolled. All demographic, anthropometric, laboratory, radiological, clinical and microbiological data will be collecte...
Eligibility Criteria
Inclusion
- Patients that can give written or oral informed consent
- patients with microbiological diagnosis (i.e. rhinopharyngeal swab) of SARS-CoV2 infection
Exclusion
- severe cognitive impairment
- absolute contraindication to non invasive ventilation or cpap therapy
- rhinopharyngeal swab negative for SARS-CoV2
Key Trial Info
Start Date :
March 19 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04307459
Start Date
March 19 2020
End Date
December 31 2020
Last Update
May 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Luigi Sacco University Hospital
Milan, Lombardy, Italy, 20157